During the past decade, RCMed conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RCMed" #1 sponsor was "R-Pharm International, LLC" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Gedeon Richter Plc." with 1 trials sponsored and "IBSA Institut Biochimique SA" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RCMed" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "RCMed" are "Rheumatoid Arthritis" (5 trials), "Ankylosing Spondylitis" (1 trials), "Knee Osteoarthritis" (1 trials), "Non-Radiographical Axial Spondyloarthritis" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "RCMed" in a lesser frequency.

Most popular intervention types in "RCMed" are "Drug" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Adalimumab 40mg q2w" (1 trials) and "Concomitant treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "RCMed" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "RCMed". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in RCMed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RCMed, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".